MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.515
-0.025 (-1.62%)
May 9, 2025, 10:32 AM - Market open
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $95.58 million as of May 9, 2025. Its market cap has decreased by -90.07% in one year.
Market Cap
95.58M
Enterprise Value
-68.62M
1-Year Change
-90.07%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $95.58M, a decrease of -84.08%. That is a compound annual growth rate of -14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 94.00M | -53.92% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.85B |
| Johnson & Johnson | 371.67B |
| UnitedHealth Group | 359.09B |
| AbbVie | 331.06B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |